US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Recruiting clinical trials with at least one study location in Wisconsin. Data updated daily from ClinicalTrials.gov.

Total Trials
186
Recruiting Now
186
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (6)Stage IVB Prostate Cancer AJCC v8 (4)Chronic Lymphocytic Leukemia (4)Stroke (3)Small Lymphocytic Lymphoma (3)Asthma (3)Cardiovascular Diseases (3)Castration-Resistant Prostate Carcinoma (3)Prostate Cancer (3)PTSD (2)Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 186 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 186. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Stage IVB Prostate Cancer AJCC v8, Chronic Lymphocytic Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT05797610 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Partici...
Condition
Primary IgA Nephropathy
Enrollment
428 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT05327114 Phase 2, Phase 3
Recruiting
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory De...
Condition
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Enrollment
201 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT07076121 Phase 2, Phase 3
Recruiting
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine ...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06686771 Phase 3
Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Condition
Non-small Cell Lung Cancer
Enrollment
320 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT06863207 N/A
Recruiting
Autonomic Reactivity and Personalized Neurostimulation
Condition
Functional Gastrointestinal Disorders (FGIDs)
Enrollment
120 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT04333537 Phase 2, Phase 3
Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Pat...
Condition
Buccal Mucosa Squamous Cell Carcinoma
Enrollment
686 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT05684965 Phase 1, Phase 2
Recruiting
XTX301 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
358 pts
Location
United States
Sponsor
Xilio Development, Inc.
View Trial →
NCT05866471 Phase 1
Recruiting
The ENHANCE Study: taVNS and Psilocybin
Condition
Healthy
Enrollment
108 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06848348 Phase 2
Recruiting
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced ...
Condition
Chemotherapy Induced Neuropathic Pain
Enrollment
200 pts
Location
United States
Sponsor
Dogwood Therapeutics Inc.
View Trial →
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
View Trial →
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05023434 N/A
Recruiting
A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function...
Condition
Brain Tumor
Enrollment
20 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT05068232 Phase 2
Recruiting
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
Condition
Small-cell Lung Cancer
Enrollment
49 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT05503264 Phase 3
Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodyn...
Condition
NMDAR Autoimmune Encephalitis
Enrollment
152 pts
Location
United States, Argentina, Austria
Sponsor
Hoffmann-La Roche
View Trial →
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT04068012 N/A
Recruiting
Clinical Decision Support Tool in PARDS Pilot Study
Condition
Ventilation Therapy; Complications
Enrollment
180 pts
Location
United States, Canada, Italy
Sponsor
Children's Hospital Los Angele
View Trial →
NCT06423430 N/A
Recruiting
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Condition
Treatment Resistant Depression
Enrollment
100 pts
Location
United States
Sponsor
Abbott Medical Devices
View Trial →
NCT03232918 Phase 4
Recruiting
Oxytocin and Fetal Heart Rate Changes
Condition
Fetal Bradycardia Complicating Labor and Delivery
Enrollment
730 pts
Location
United States
Sponsor
Unyime Ituk
View Trial →
NCT06578247 Phase 3
Recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-I...
Condition
Leukemia
Enrollment
700 pts
Location
United States, Australia, Austria
Sponsor
Daiichi Sankyo
View Trial →
NCT04509050 N/A
Recruiting
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR ...
Condition
Cystic Fibrosis
Enrollment
210 pts
Location
United States
Sponsor
Sonya Heltshe
View Trial →
NCT06930638 Phase 2
Recruiting
MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes
Condition
Stroke
Enrollment
30 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT07422285 Phase 1
Recruiting
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in...
Condition
Healthy Participants
Enrollment
400 pts
Location
United States
Sponsor
Amgen
View Trial →
NCT05135091 Phase 3
Recruiting
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Tempo...
Condition
Mesial Temporal Lobe Epilepsy
Enrollment
88 pts
Location
United States
Sponsor
Neurona Therapeutics
View Trial →
Page 3 of 8 — 186 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology